The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer
Open Access
Abstract
The role of magnetic resonance imaging (MRI) in rectal cancer management has significantly increased over the last decade, in line with more personalized treatment approaches. Total neoadjuvant treatment (TNT) plays a pivotal role in the shift from traditional surgical approach to non-surgical approaches such as ‘watch-and-wait’. MRI plays a central role in this evolving landscape, providing essential morphological and functional data that support clinical decision-making. Key MRI-based biomarkers, including circumferential resection margin (CRM), extramural venous invasion (EMVI), tumour deposits, diffusion-weighted imaging (DWI), and MRI tumour regression grade (mrTRG), have proven valuable for staging, response assessment, and patient prognosis. Functional imaging techniques, such as dynamic contrast-enhanced MRI (DCE-MRI), alongside emerging biomarkers derived from radiomics and artificial intelligence (AI) have the potential to transform rectal cancer management offering data that enhance T and N staging, histopathological characterization, prediction of treatment response, recurrence detection, and identification of genomic features. This review outlines validated morphological and functional MRI-derived biomarkers with both prognostic and predictive significance, while also exploring the potential of radiomics and artificial intelligence in rectal cancer management. Furthermore, we discuss the role of rectal MRI in the ‘watch-and-wait’ approach, highlighting important practical aspects in selecting patients for non-surgical management.Keywords
This publication has 186 references indexed in Scilit:
- Tumor deposits in colorectal cancer: Refining their definition in the TNM systemAnnals of Gastroenterological Surgery, 2023
- Development and validation of MRI‐based deep learning models for prediction of microsatellite instability in rectal cancerCancer Medicine, 2021
- Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal CancerJAMA Network Open, 2020
- Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary SurgeryJAMA Oncology, 2019
- MRI‐based radiomics signature for tumor grading of rectal carcinoma using random forest modelJournal of Cellular Physiology, 2019
- Diffusion‐weighted MRI in rectal cancer: Apparent diffusion coefficient as a potential noninvasive marker of tumor aggressivenessJournal of Magnetic Resonance Imaging, 2012
- Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excisionBritish Journal of Surgery, 2010
- Predicting and monitoring cancer treatment response with diffusion‐weighted MRIJournal of Magnetic Resonance Imaging, 2010
- Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancerBritish Journal of Surgery, 2008
- Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imagingBritish Journal of Surgery, 2003